Ocular activity of topically administered anandamide in the rabbit

Japanese Journal of Ophthalmology

Volumn 41, Issue 4, 1997, Pages 217-220

  Mikawa, Yoichi ^a   Matsuda, Satoshi ^a   Kanagawa, Tomoko ^a   Tajika, Tomoyuki ^a   Ueda, Natsuo ^a   Mimura, Yasuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Anandamide; Cannabinoid; Intraocular pressure; Rabbit

Indexed keywords

ANANDAMIDE; CANNABINOID; MINERAL OIL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CONJUNCTIVA; DRUG ACTIVITY; HYPEREMIA; INTRAOCULAR PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACIDS; CALCIUM CHANNEL BLOCKERS; CONJUNCTIVA; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPEREMIA; INTRAOCULAR PRESSURE; MALE; OCULAR HYPOTENSION; OPHTHALMIC SOLUTIONS; PALMITIC ACIDS; POLYUNSATURATED ALKAMIDES; PUPIL; RABBITS;

EID: 0030723870     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(97)00050-6     Document Type: Article

References (23)

1. Dewey WL. Cannabinoid pharmacology. Pharmacol Rev 1986; 38:151-78.
2. Hepler RS, Frank IM. Marijuana smoking and intraocular pressure. J Am Med Assoc 1971;217:1392.
3. 1-tetrahydrocannabinol on aqueous dynamics and ciliary body permeability in the rabbit. Exp Eye Res 1973;15:499-507.
4. Green K, Bigger JF, Kim K, et al. Cannabinoid action on the eye as mediated through the central nervous system and local adrenergic activity. Exp Eye Res 1977;24:189-96.
5. Devane WA, Dysarz FA III, Johnson MR, et al. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988;34:605-13.
6. Matsuda LA, Lolait SJ, Brownstein MJ, et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346:561-4.
7. Gérard CM, Mollereau C, Vassart G, et al. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 1991;279:129-34.
8. Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-9.
9. Vogel Z, Barg J, Levy R, et al. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 1993;61:352-5.
10. Felder CC, Briley EM, Axelrod J, et al. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci USA 1993;90:7656-60.
11. Fride E, Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol 1993;231:313-4.
12. Smith PB, Compton DR, Welch SP, et al. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharm Exp Ther 1994;270:219-27.
13. Pate DW, Järvinen K, Urtti A, et al. Ophthalmic arachidonyl-ethanolamide decreases intraocular pressure in normotensive rabbits. Curr Eye Res 1995;14:791-7.
14. Pate DW, Järvinen K, Urtti A, et al. Effects of topical anandamides on intraocular pressure in normotensive rabbits. Life Sci 1996;58:1849-60.
15. Di Marzo V, Fontana A. Anandamide, an endogenous cannabinomimetic eicosanoid: "Killing two birds with one stone." Prostaglandins Leukot Essent Fatty Acids 1995;53:1-11.
16. Hepler RS, Franks IM, Ungerleider JT. Pupillary constriction after marijuana smoking. Am J Ophthalmol 1972;74:1185-90.
17. Weil AT, Zinberg NE, Nelsen JM. Clinical and psychological effects of marihuana in man. Science 1968;162:1234-42.
18. Munro S, Thomas KI, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365:61-5.
19. Deutsch DG, Chin SA. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 1993;46:791-6.
20. Matsuda S, Kanemitsu N, Nakamura A, et al. Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. Exp Eye Res, in press.
21. Green K, Kim K. Mediation of ocular tetrahydrocannabinol effects by adrenergic nervous system. Exp Eye Res 1976; 23:443-8.
22. Burstein S, Varanelli C, Slade LT. Prostaglandins and cannabis: III. Inhibition of biosynthesis by essential oil components of marihuana. Biochem Pharmacol 1975;24:1053-4.
23. Martin BR. Cellular effects of cannabinoids. Pharmacol Rev 1986;38:45-74.